Stay updated on Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial page.

Latest updates to the Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedUpdated the page revision from v3.6.3 to v3.6.4, signaling a software update to the ClinicalTrials.gov page rendering; there is no change to the study details themselves.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedNew revision tag Revision: v3.6.3 has been added, replacing Revision: v3.6.0. This indicates a minor update to the page’s revision history or release notes.SummaryDifference0.0%

- Check46 days agoChange DetectedRecruitment status now shows no further participant enrollment; new help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label formatting was adjusted, with the revision updated to v3.6.0.SummaryDifference0.4%

- Check53 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing Revision: v3.5.4. This indicates a small update to the page's underlying revision rather than a change to study details.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4 on the page, signaling a new release of the site rendering. The content and study details remain unchanged aside from metadata.SummaryDifference0.0%

- Check96 days agoChange DetectedThe page footer revision label has been updated from **Revision: v3.5.0** to **Revision: v3.5.3**.SummaryDifference0.0%

Stay in the know with updates to Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial page.